CN107279369A - A kind of preparation method of hypoglycemic yellow tea - Google Patents
A kind of preparation method of hypoglycemic yellow tea Download PDFInfo
- Publication number
- CN107279369A CN107279369A CN201710423277.9A CN201710423277A CN107279369A CN 107279369 A CN107279369 A CN 107279369A CN 201710423277 A CN201710423277 A CN 201710423277A CN 107279369 A CN107279369 A CN 107279369A
- Authority
- CN
- China
- Prior art keywords
- yellow tea
- polyphenols
- hypoglycemic
- tea
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020338 yellow tea Nutrition 0.000 title claims abstract description 135
- 230000002218 hypoglycaemic effect Effects 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000008280 blood Substances 0.000 claims abstract description 57
- 210000004369 blood Anatomy 0.000 claims abstract description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 38
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 35
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 35
- 239000000284 extract Substances 0.000 claims abstract description 33
- 239000000126 substance Substances 0.000 claims abstract description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 6
- 238000000926 separation method Methods 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 21
- 239000000706 filtrate Substances 0.000 claims description 19
- 238000001556 precipitation Methods 0.000 claims description 15
- 235000019441 ethanol Nutrition 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 238000002390 rotary evaporation Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 235000013402 health food Nutrition 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000013517 stratification Methods 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 239000002893 slag Substances 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 235000013616 tea Nutrition 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 5
- 238000000605 extraction Methods 0.000 abstract description 4
- 230000000291 postprandial effect Effects 0.000 abstract description 4
- 208000013016 Hypoglycemia Diseases 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 241001122767 Theaceae Species 0.000 abstract 2
- 238000013329 compounding Methods 0.000 abstract 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 abstract 1
- 239000008103 glucose Substances 0.000 description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 15
- 244000269722 Thea sinensis Species 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 230000009467 reduction Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000003305 oral gavage Methods 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000002110 toxicologic effect Effects 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002073 mitogenetic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/18—Extraction of water soluble tea constituents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of preparation method of hypoglycemic yellow tea, belong to hypoglycemia healthcare food field.The present invention prepares hypoglycemic yellow tea method after reconfiguring yellow tea polysaccharose substance and yellow tea polyphenols.It is characterized in that using yellow tea as raw material, by hot-water soak, Ultrasonic Wave-Assisted Extraction, polysaccharose substance and polyphenols in separation of ethanol water extract, and by polysaccharose substance and polyphenols according to parts by weight 1:(0.2 6) compounding prepares new hypoglycemic yellow tea again, and the yellow tea of preparation can reduce postprandial blood sugar, and effect is better than former tea extraction material, and yellow tea polysaccharose substance and yellow tea polyphenols of the former tea extract after separation of ethanol.It is raw material that the present invention, which chooses commercially available yellow tea, and raw material sources are extensive, safety, and the novel blood sugar lowing yellow tea prepared according to this method reduces postprandial blood sugar effect substantially, is adapted to use postprandial blood sugar sensitive group.
Description
Technical field
The present invention relates to a kind of preparation method of hypoglycemic yellow tea, belong to hypoglycemia healthcare food field.
Background technology
Blood glucose value is hyperglycaemia higher than normal range (NR);Fasting blood-glucose>6.1mmol/L, after the meal two hours blood glucose value>
7.8mmol/L, referred to as hyperglycaemia.Under normal circumstances, maintain internal blood glucose steady by hormone control and nerve modulation in body
Surely in normal range (NR);Inherent cause (if any family's diabetic history) and environmental factor (high fat high-carbohydrate diet, it is unsound
Life style is such as smoked excessive drinking) collective effect under, two big regulating systems get muddled in body, cause blood glucose value to raise,
There is hyperglycaemia.
It is chronically in the case of hyperglycaemia, it is very harmful to body, body tissue organ lesion, inducing acute is occurred
The exhaustion of the generation of chronic complicating diseases, such as pancreas function, dehydration, body electrolyte imbalance, malnutrition, resistance decline, kidney
Exhaustion etc..Therefore control body blood glucose balance stablizes most important.
At present, the method that diabetes are not effected a radical cure is directed to, pancreas islet either can only be injected by oral hypoglycemic drug
Element method come control blood glucose be in stable state, and long-term taking antidiabetic drug either insulin injection easily body pancreas is occurred
Island element sensitiveness reduction, so that need to increase dosage, and heavy dose can trigger drug safety using medicine, harm is strong
Health.
In recent years, the effects such as numerous studies show to drink tea with Weight-reducing and lipid-lowering, anti-oxidant, regulation blood glucose.Although having reported
Road discloses Huang great Cha has a significant function of blood sugar reduction compared with green tea, black tea, and is that any component is either in tealeaves actually
Ratio change between different component has leading role still unknown to hypoglycemic.
Although there are reports has using many polyphenol extracts of green tea tea and green tea tea polysaccharide extract or the two is common
Effect reduction blood glucose in diabetic mice, but these methods generally require under very high concentration just it is effective (under normal circumstances,
Be not up to so high concentration), blood sugar decreasing effect have it is to be reinforced, need to buy commercialization polysaccharide or polyphenol substance etc. and ask
Topic.At present, report still not on yellow tea extract combination.
The content of the invention
In view of the above-mentioned problems, the invention provides reconfigure preparation between a kind of extraction of yellow tea tea component and composition
The method of novel blood sugar lowing yellow tea.Present invention discover that by the polyphenols extracted from yellow tea and polysaccharose substance according to certain
After proportioning is mixed, with good blood sugar decreasing effect, and toxicological experiment proves that mixture is nontoxic.
First purpose of the present invention is to provide a kind of preparation method of hypoglycemic yellow tea, and methods described is first from yellow tea water
The polysaccharose substance of the polyphenols of isolated alcohol-soluble and alcohol precipitation in extract solution, then by obtained Polyphenols thing
Matter and polysaccharose substance are according to weight ratio 1:(0.2~6) is mixed to get.
In one embodiment, the yellow tea water extract solution, is that first will crush yellow tea, with hot-water soak, ultrasound
Processing, filtering, then take filter residue and repeat hot-water soak, ultrasonically treated, filtration step 1~5 time, and merging filtrate removes filtrate
In suspended particulate be to obtain yellow tea water extract solution.
In one embodiment, the preparation of the yellow tea water extract solution, be specifically:The yellow tea after crushing is taken, according to
Material-water ratio 1:8~1:12 add 70~100 DEG C of 5~15min of hot-water soak, then ultrasonically treated 3~8min, then soak 5~
15min;Then it is collected by filtration filtrate, and filter residue is repeated into hot-water soak, ultrasonically treated, filtration step 1~5 time;Merging filtrate,
Flocculant is added in filtrate, removes after suspended particulate, obtains yellow tea water extract solution.
In one embodiment, the polyphenols of the alcohol-soluble, is to steam yellow tea water extract solution vacuum rotating
Hair concentration, adds the absolute ethyl alcohol of certain volume in yellow tea flooding extract after concentration, it is agitated, stand, it is isolated on
Clear liquid, supernatant concentrates, is dried to obtain the polyphenols of alcohol-soluble through rotary evaporation in vacuo.
In one embodiment, the rotary evaporation in vacuo concentration is carried out under -0.1MP vacuums.
In one embodiment, the addition volume of the absolute ethyl alcohol is 2~6 times of yellow tea flooding extract.
In one embodiment, drying is dried or vacuum freeze drying in vacuum drying chamber.
In one embodiment, the polysaccharose substance of the alcohol precipitation, is to steam yellow tea water extract solution vacuum rotating
Hair concentration, adds the absolute ethyl alcohol of certain volume in yellow tea flooding extract after concentration, it is agitated, stand, it is isolated heavy
Form sediment, precipitate the polysaccharose substance through being dried to obtain alcohol precipitation.
In one embodiment, the preparation method, specifically includes following steps:
(1) yellow tea after 100g crushing is taken to be put into 1000mL water, 90 DEG C of immersion 10min, ultrasonically treated 5 minutes, room temperature
Soak 10min;Then with three layers of filtered through gauze, filtrate is taken, filter residue is preserved;
(2) gained filter residue in step (1) is taken, hot-water soak and ultrasonic processing technique is repeated, then with three layers of filtered through gauze,
Filter residue is lost, filtrate is taken and merges with the filtrate in step (1);
(3) flocculant is added in filtrate, removes after suspended particulate, obtains yellow tea water extract solution;
(4) by yellow tea water extract solution under -0.1MP vacuums, rotary evaporation is concentrated, then yellow tea water after concentration
The absolute ethyl alcohol of 4 times of volumes is added in extract, 10min is stirred;After stratification, separation supernatant and precipitation;
(5) supernatant is rotated into evaporation and concentration under -0.1MP vacuum, and concentrate is done in vacuum drying chamber
It is dry into powder, obtain the yellow tea polyphenols powder of alcohol-soluble;
(6) vacuum freeze drying at -45 DEG C will be deposited in and, into powder, obtain the yellow tea polysaccharose substance powder of alcohol precipitation;
(7) the yellow tea polysaccharose substance powder that the yellow tea polyphenols powder and step (6) obtained step (5) is obtained according to
Weight compares 1:(0.2~6) is mixed, that is, obtains hypoglycemic yellow tea.
In one embodiment, flocculant is organic or inorganic flocculant in the step (3).
In one embodiment, in the hypoglycemic yellow tea yellow tea polysaccharose substance and yellow tea polyphenols weight
Than for 1:2~1:6.
In one embodiment, the weight ratio of yellow tea polysaccharose substance and yellow tea polyphenols is 1:0.2、1:0.5、
1:1、1:2、1:4 or 1:6.
In one embodiment, the hypoglycemic yellow tea is configured to the solution that concentration is 12mg/mL~500mg/mL.
In one embodiment, the yellow tea raw material is to originate from the Huang that your Zhong Xiu companies production is embraced by Huoshan County of Anhui Province
Tea.
In one embodiment, the yellow tea can be Huang little Cha or Huang great Cha.
In one embodiment, the preparation technology of the yellow tea:Fresh leaf → withering → finishes → kneaded, and → vexed Huang → is dry
It is dry.
In one embodiment, the specific preparation technology of the yellow tea is:By taking Huang great Cha as an example, manufacturing procedure is divided into stir-fry
Tea, just baking, accumulation, baking.
In one embodiment, the yellow big tea process:(1) tea frying:Mitogenetic pot, two blue or green pots, three steps of ripe pot
Suddenly.Raw pot mainly plays fixing, the activity of destructive enzyme;Two blue or green pots mainly play a part of tentatively to rub bar and continue to finish;Ripe pot
Mainly further do bar;(2) just dry:Quick high-temp is bakeed after stir-fry, and temperature is 120 DEG C or so, throw leaf amount be per hand-held basketwork brazier 2~
2.5kg, every 2~3 minutes turned over baking once, are dried about 30 minutes, and up to doing very likely, breaking for tea stalk folding, is appropriateness;(3) accumulate:
Tealeaves is filled to basket while hot after lower baking or is piled up in circle seat and is slightly compressed, high about 1m is placed in dry drying room, utilizes drying room
Heat promote xanthochromia.Depending on old tender, the tea base water content size of the accumulation time visual fresh leaf of length and xanthochromia degree, 5 are typically required
~7 days;Leaf color xanthochromia is stacked into, fragrance is revealed as moderately, and as reactor startup is bakeed;(4) bakee:It is further using high temperature
Promote the conversion of xanthochromia and endoplasm, it is fragrant to form the yellow big distinctive crispy rice of tea in Huoshan.
Second object of the present invention is to provide the hypoglycemic yellow tea prepared according to the method described above.
Third object of the present invention is to provide a kind of hypoglycemic medicine composition or health food, the drug regimen
Thing or health food are using the hypoglycemic yellow tea of the present invention as principle active component.
In one embodiment, described pharmaceutical composition also includes pharmaceutically acceptable excipients.It is described pharmaceutically
Acceptable excipients refer to any diluent, adjuvant and/or carrier available for pharmaceutical field.
In one embodiment, the hypoglycemic yellow tea can be applied in combination with other active components, as long as they are not
Produce other unfavorable effects, such as allergic reaction.
In one embodiment, described pharmaceutical composition can be configured to several formulation, wherein containing in pharmaceutical field
Some conventional excipient;For example, oral formulations (such as tablet, capsule, solution or suspension);The preparation of injectable (such as may be used
The solution or suspension of injection, or injectable dried powder, before the injection add water for injection can use immediately);Office
Portion's preparation (such as ointment or solution).
In one embodiment, the carrier for the pharmaceutical composition of the present invention is available common in pharmaceutical field
Type, including:It is the adhesives of oral formulations, lubricant, disintegrant, cosolvent, diluent, stabilizer, suspending agent, colourless
Element, flavouring etc.;Preservative, solubilizer, stabilizer of injectable formulation etc.;Matrix, diluent, the lubrication of topical formulations
Agent, preservative etc..Pharmaceutical preparation can by oral administration or parenteral (such as intravenous, subcutaneous, intraperitoneal or local) administration,
If some drugses are unstable under the conditions of stomach, enteric coated tablets can be configured to.
The present invention also provides application of the hypoglycemic yellow tea in terms of blood sugar reducing preparation is prepared.
Beneficial effects of the present invention:
The present invention uses the polyphenols powder in yellow tea and the allotment of polysaccharose substance powder, with good hypoglycemic work(
Can, and yellow tea polyphenols powder or yellow tea polysaccharose substance powder is used alone without blood sugar decreasing effect.And yellow tea polyphenol
Class material and yellow tea polysaccharose substance are all from yellow tea tealeaves, and the toxicological experiment of material proves that mixture is nontoxic after allotment.
Brief description of the drawings
Fig. 1 is the hypoglycemic effect of different formulations yellow tea.
Embodiment
The invention discloses a kind of preparation method of novel blood sugar lowing yellow tea.Those skilled in the art can be by this paper
Hold, be suitably modified Extraction technique realization.In particular, all similar replacements and change to the skill of this area
It is it will be apparent that they are considered as being included in the present invention for art personnel.Method of the present invention and combinations thereof application is
Illustrate explanation by preferable case study on implementation, related personnel substantially can be not departing from present invention, in spirit and scope to this
Methods and applications described in text are modified or suitably change is with combining, to realize and apply the technology of the present invention.
Prepared by the novel blood sugar lowing yellow tea that the present invention is provided raw materials used is commercially available.With reference to specific implementation
Case, is expanded on further the present invention:
Embodiment 1:The preparation method of hypoglycemic yellow tea
The yellow tea after 100g crushing is taken to be put into 1000mL deionized waters, 90 DEG C of immersion 10min, ultrasonically treated 5 minutes, room
Temperature immersion 10min.Then with three layers of filtered through gauze, filtrate is taken, filter residue is preserved.Filter residue is repeated into hot-water soak and ultrasonically treated work
Skill, then with three layers of filtered through gauze, abandons filter residue, obtains filtrate, and merge with first step filtrate.Then flocculation is added in filtrate
Agent, removes after suspended particulate, obtains yellow tea water extract solution.By yellow tea water extract solution under -0.1MP vacuums, rotation is steamed
Hair concentration, then adds the absolute ethyl alcohol of 4 times of volumes in yellow tea flooding extract after concentration, stir 10min.Stratification
Afterwards, isolated supernatant and precipitation.Supernatant is rotated into evaporation and concentration under -0.1MP vacuum, and by concentrate true
Powder is dried in empty drying box, the yellow tea polyphenols powder of alcohol-soluble is obtained.To be deposited at -45 DEG C vacuum freeze drying into
Powder, obtains the yellow tea polysaccharose substance powder of alcohol precipitation.
1 parts by weight yellow tea polysaccharose substance and 0.2 parts by weight yellow tea polyphenols are mixed to prepare novel blood sugar lowing yellow
Tea.
Embodiment 2
The preparation method of novel blood sugar lowing yellow tea is substantially the same manner as Example 1, differs only in:
1 parts by weight yellow tea polysaccharose substance and 0.5 parts by weight yellow tea polyphenols are mixed to prepare novel blood sugar lowing yellow
Tea.
Embodiment 3
The preparation method of novel blood sugar lowing yellow tea is substantially the same manner as Example 1, differs only in:
1 parts by weight yellow tea polysaccharose substance and 1 parts by weight yellow tea polyphenols are mixed to prepare novel blood sugar lowing yellow tea.
Embodiment 4
The preparation method of novel blood sugar lowing yellow tea is substantially the same manner as Example 1, differs only in:
1 parts by weight yellow tea polysaccharose substance and 2 parts by weight yellow tea polyphenols are mixed to prepare novel blood sugar lowing yellow tea.
Embodiment 5
The preparation method of novel blood sugar lowing yellow tea is substantially the same manner as Example 1, differs only in:
1 parts by weight yellow tea polysaccharose substance and 4 parts by weight yellow tea polyphenols are mixed to prepare novel blood sugar lowing yellow tea.
Embodiment 6
The preparation method of novel blood sugar lowing yellow tea is substantially the same manner as Example 1, differs only in:
1 parts by weight yellow tea polysaccharose substance and 6 parts by weight yellow tea polyphenols are mixed to prepare novel blood sugar lowing yellow tea.
Embodiment 7
The preparation method of novel blood sugar lowing yellow tea is substantially the same manner as Example 1, differs only in:
Novel blood sugar lowing yellow tea is made by 1 parts by weight yellow tea polysaccharose substance.
Embodiment 8
The preparation method of novel blood sugar lowing yellow tea is substantially the same manner as Example 1, differs only in:
Novel blood sugar lowing yellow tea is made by 1 parts by weight yellow tea polyphenols.
Embodiment 9:The function of blood sugar reduction experiment of function of blood sugar reduction yellow tea
1. experiment purpose:Hypoglycemic yellow tea of the invention is studied to mouse reducing postprandial blood glucose
2. experiment material:
Main agents:The hypoglycemic yellow tea of the present invention, glucose
Experimental animal:SPF grades of male ICR mouses, 80, body weight (30 ± 2) g
Laboratory apparatus:Blood glucose meter and blood sugar test paper, Johnson Co.
3. test method:Normal diet raised mouse after one week, and it (is respectively glucose group, yellow tea water to be randomly divided into 10 groups
Extract group, 1 group of embodiment, 2 groups of embodiment, 3 groups of embodiment, 4 groups of embodiment, 5 groups of embodiment, 6 groups of embodiment, 7 groups of embodiment,
8 groups of embodiment;Wherein yellow tea water extract group is that the aqueous solution for obtaining tea into hot water is concentrated and dried what is obtained), mouse
After fasting 8 hours, fasting blood sugar is determined.The glucose of the oral gavage 1g pers kilogram of body weight of glucose control group, yellow tea water extraction
Thing group gavage yellow tea water extract, the every kg body weight of glucose and 0.5g of the oral gavage 1g of remaining 8 groups of difference per kg body weight
The not novel blood sugar lowing yellow tea in be the same as Example, respectively at 15 minutes after gavage, 30 minutes, 45 minutes, 60 minutes, afterbody was adopted
Blood, surveys blood glucose value.
4. blood glucose test results are characterized
Blood glucose rise index=(blood glucose value-fasting blood sugar)/fasting blood sugar
Blood glucose value-in the blood glucose value of different time points detection
Mouse blood sugar value before fasting blood sugar-gavage
5. experimental result
Wherein, such as table 1 and Fig. 1 of the blood glucose rise index after different time.
Mouse blood sugar raises index under the different experiments group of table 1
0min | 15min | 30min | 45min | 60min | |
Glucose group | 0 | 1.07 | 0.86 | 0.62 | 0.51 |
Yellow tea water extract group | 0 | 0.94 | 0.58 | 0.44 | 0.23 |
Embodiment 1 | 0 | 1.04 | 0.73 | 0.52 | 0.27 |
Embodiment 2 | 0 | 0.97 | 0.63 | 0.48 | 0.24 |
Embodiment 3 | 0 | 0.92 | 0.60 | 0.36 | 0.31 |
Embodiment 4 | 0 | 0.69 | 0.43 | 0.22 | 0.24 |
Embodiment 5 | 0 | 0.56 | 0.30 | 0.20 | 0.07 |
Embodiment 6 | 0 | 0.82 | 0.37 | 0.31 | 0.16 |
Embodiment 7 | 0 | 1.12 | 0.92 | 0.68 | 0.65 |
Embodiment 8 | 0 | 1.05 | 0.91 | 0.51 | 0.40 |
Fig. 1 and the result of table 1 show, yellow tea polysaccharose substance and Huang of the yellow tea polyphenols according to different weight than preparation
Tea is respectively provided with hypoglycemic effect, and the hypoglycemic effect of the yellow tea of embodiment 5 is best.Yellow tea tea polysaccharide class material and yellow tea tea are more
This experiment of aldehydes matter does not show blood sugar decreasing effect.
Claims (10)
1. a kind of preparation method of hypoglycemic yellow tea, it is characterised in that methods described is first to be separated from yellow tea water extract solution
The polyphenols of alcohol-soluble and the polysaccharose substance of alcohol precipitation are obtained, then by obtained polyphenols and polysaccharose substance
Compare 1 according to weight:(0.2~6) is mixed to get.
2. it is according to the method described in claim 1, it is characterised in that the polyphenols of the alcohol-soluble, by yellow tea water extraction
Thing solution rotary evaporation in vacuo is concentrated, the absolute ethyl alcohol of addition certain volume in yellow tea flooding extract after concentration, agitated,
Standing, isolated supernatant, supernatant concentrate, are dried to obtain the polyphenols of alcohol-soluble through rotary evaporation in vacuo;It is described
The polysaccharose substance of alcohol precipitation, is by the concentration of yellow tea water extract solution rotary evaporation in vacuo, yellow tea flooding extract after concentration
The middle absolute ethyl alcohol for adding certain volume, agitated, standing, isolated precipitation, precipitates the polysaccharide through being dried to obtain alcohol precipitation
Class material.
3. according to the method described in claim 1, it is characterised in that in the hypoglycemic yellow tea polyphenols of alcohol-soluble and
The weight ratio of the polysaccharose substance of alcohol precipitation is 1:2~1:6.
4. according to the method described in claim 1, it is characterised in that the polyphenols of alcohol-soluble and the polysaccharide thing of alcohol precipitation
The weight ratio of matter is 1:0.2、1:0.5、1:1、1:2、1:4 or 1:6.
5. it is according to the method described in claim 1, it is characterised in that the yellow tea water extract solution, that first will crush yellow tea,
With hot-water soak, ultrasonically treated, filtering, then take filter residue and repeat hot-water soak, ultrasonically treated, filtration step 1~5 time, close
And filtrate, the suspended particulate removed in filtrate is to obtain yellow tea water extract solution.
6. according to the method described in claim 1, it is characterised in that the preparation method specifically includes following steps:
(1) yellow tea after 100g crushing is taken to be put into 1000mL water, 90 DEG C of immersion 10min, ultrasonically treated 5 minutes, soaking at room temperature
10min;Then with three layers of filtered through gauze, filtrate is taken, filter residue is preserved;
(2) gained filter residue in step (1) is taken, hot-water soak and ultrasonic processing technique is repeated, then with three layers of filtered through gauze, loses filter
Slag, takes filtrate and merges with the filtrate in step (1);
(3) flocculant is added in filtrate, removes after suspended particulate, obtains yellow tea water extract solution;
(4) by yellow tea water extract solution under -0.1MP vacuums, rotary evaporation is concentrated, then yellow tea flooding after concentration
The absolute ethyl alcohol of 4 times of volumes is added in thing, 10min is stirred;After stratification, separation supernatant and precipitation;
(5) supernatant is rotated into evaporation and concentration under -0.1MP vacuum, and concentrate is dried in vacuum drying chamber
Powder, obtains the yellow tea polyphenols powder of alcohol-soluble;
(6) vacuum freeze drying at -45 DEG C will be deposited in and, into powder, obtain the yellow tea polysaccharose substance powder of alcohol precipitation;
(7) the yellow tea polysaccharose substance powder that the yellow tea polyphenols powder and step (6) obtained step (5) is obtained is according to weight
Than 1:(0.2~6) is mixed, that is, obtains hypoglycemic yellow tea.
7. the hypoglycemic yellow tea prepared according to any methods described of claim 1~6.
8. a kind of hypoglycemic medicine composition or health food, it is characterised in that described pharmaceutical composition or health food
Using the hypoglycemic yellow tea described in claim 7 as principle active component.
9. pharmaceutical composition according to claim 8, it is characterised in that described pharmaceutical composition also includes pharmaceutically connecing
The excipients received.
10. application of the hypoglycemic yellow tea in terms of blood sugar reducing preparation is prepared described in claim 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710423277.9A CN107279369A (en) | 2017-06-07 | 2017-06-07 | A kind of preparation method of hypoglycemic yellow tea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710423277.9A CN107279369A (en) | 2017-06-07 | 2017-06-07 | A kind of preparation method of hypoglycemic yellow tea |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107279369A true CN107279369A (en) | 2017-10-24 |
Family
ID=60096197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710423277.9A Pending CN107279369A (en) | 2017-06-07 | 2017-06-07 | A kind of preparation method of hypoglycemic yellow tea |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107279369A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111793660A (en) * | 2020-09-02 | 2020-10-20 | 安徽大学 | A radix et rhizoma Rhei tea polysaccharide with blood sugar lowering effect |
Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1176748A (en) * | 1997-05-17 | 1998-03-25 | 严良荣 | Process for extracting polysaccharide and polyphenol mixed crystal from fresh crude and old tea leaves |
CN1557841A (en) * | 2004-01-14 | 2004-12-29 | 中国农业科学院茶叶研究所 | Process for synthetic extraction of polysaccharides, tea-polyphenol, theanine, caffeine from tea |
CN1634913A (en) * | 2003-12-31 | 2005-07-06 | 中国海洋大学 | Process for preparing effective constituent in tea |
CN101113147A (en) * | 2007-06-26 | 2008-01-30 | 朱江 | Method for tea by-product resource utilization |
CN101167590A (en) * | 2007-12-03 | 2008-04-30 | 黄宝生 | Beverage containing tea polysaccharide |
CN101519458A (en) * | 2009-03-26 | 2009-09-02 | 天津大学 | Method for extracting tea polysaccharides and tea polyphenol from coarse old green tea |
CN101961059A (en) * | 2009-07-24 | 2011-02-02 | 天津天士力现代中药资源有限公司 | Puer tea extract, preparation method and application |
CN101961061A (en) * | 2009-07-24 | 2011-02-02 | 天津天士力现代中药资源有限公司 | Pu-erh tea extract, preparation method and application |
CN102293277A (en) * | 2010-06-23 | 2011-12-28 | 郁丽华 | Preparation method of weight-losing health-care product |
CN102342339A (en) * | 2011-07-01 | 2012-02-08 | 广东正源华茶生物工程有限公司 | Standard quantitative-matching instant green tea and preparation method thereof |
CN102919427A (en) * | 2012-11-15 | 2013-02-13 | 戴群 | Black tea extract for effectively retaining original tea aroma and taste and preparation method and application of same |
CN102940074A (en) * | 2012-11-15 | 2013-02-27 | 戴群 | Tea extract for effectively retaining aroma and taste of original tea and preparation method and application thereof |
CN103609782A (en) * | 2013-11-14 | 2014-03-05 | 杨云帆 | Process for preparing instant drinks with rich tea polyphenols and process for preparing instant tea powder with rich tea polyphenols |
CN103704423A (en) * | 2014-01-02 | 2014-04-09 | 绿锦发展(福建)有限公司 | Preparation method for tea extract |
CN104543150A (en) * | 2015-01-23 | 2015-04-29 | 安徽农业大学 | Preparation method of low-fluorine instant tea powder |
CN105494765A (en) * | 2016-01-11 | 2016-04-20 | 福建省农业科学院茶叶研究所 | Instant tea and preparing method thereof |
CN106070840A (en) * | 2016-06-16 | 2016-11-09 | 浙江大学 | Preparation has the method for the water alcohol compatibility Folium Camelliae sinensis extract of tea scented tea color |
CN106177187A (en) * | 2016-07-26 | 2016-12-07 | 天津大学 | There is the tea polyphenol tea polysaccharide composition of efficacy enhancing and toxicity reducing antihepatocarcinoma effect |
CN106376670A (en) * | 2016-08-30 | 2017-02-08 | 广西克鲁尼茶叶生物科技有限公司 | Solid tea beverage prepared from tea polyphenol byproducts and preparation method thereof |
-
2017
- 2017-06-07 CN CN201710423277.9A patent/CN107279369A/en active Pending
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1176748A (en) * | 1997-05-17 | 1998-03-25 | 严良荣 | Process for extracting polysaccharide and polyphenol mixed crystal from fresh crude and old tea leaves |
CN1634913A (en) * | 2003-12-31 | 2005-07-06 | 中国海洋大学 | Process for preparing effective constituent in tea |
CN1557841A (en) * | 2004-01-14 | 2004-12-29 | 中国农业科学院茶叶研究所 | Process for synthetic extraction of polysaccharides, tea-polyphenol, theanine, caffeine from tea |
CN101113147A (en) * | 2007-06-26 | 2008-01-30 | 朱江 | Method for tea by-product resource utilization |
CN101167590A (en) * | 2007-12-03 | 2008-04-30 | 黄宝生 | Beverage containing tea polysaccharide |
CN101519458A (en) * | 2009-03-26 | 2009-09-02 | 天津大学 | Method for extracting tea polysaccharides and tea polyphenol from coarse old green tea |
CN101961059A (en) * | 2009-07-24 | 2011-02-02 | 天津天士力现代中药资源有限公司 | Puer tea extract, preparation method and application |
CN101961061A (en) * | 2009-07-24 | 2011-02-02 | 天津天士力现代中药资源有限公司 | Pu-erh tea extract, preparation method and application |
CN102293277A (en) * | 2010-06-23 | 2011-12-28 | 郁丽华 | Preparation method of weight-losing health-care product |
CN102342339A (en) * | 2011-07-01 | 2012-02-08 | 广东正源华茶生物工程有限公司 | Standard quantitative-matching instant green tea and preparation method thereof |
CN102919427A (en) * | 2012-11-15 | 2013-02-13 | 戴群 | Black tea extract for effectively retaining original tea aroma and taste and preparation method and application of same |
CN102940074A (en) * | 2012-11-15 | 2013-02-27 | 戴群 | Tea extract for effectively retaining aroma and taste of original tea and preparation method and application thereof |
CN103609782A (en) * | 2013-11-14 | 2014-03-05 | 杨云帆 | Process for preparing instant drinks with rich tea polyphenols and process for preparing instant tea powder with rich tea polyphenols |
CN103704423A (en) * | 2014-01-02 | 2014-04-09 | 绿锦发展(福建)有限公司 | Preparation method for tea extract |
CN104543150A (en) * | 2015-01-23 | 2015-04-29 | 安徽农业大学 | Preparation method of low-fluorine instant tea powder |
CN105494765A (en) * | 2016-01-11 | 2016-04-20 | 福建省农业科学院茶叶研究所 | Instant tea and preparing method thereof |
CN106070840A (en) * | 2016-06-16 | 2016-11-09 | 浙江大学 | Preparation has the method for the water alcohol compatibility Folium Camelliae sinensis extract of tea scented tea color |
CN106177187A (en) * | 2016-07-26 | 2016-12-07 | 天津大学 | There is the tea polyphenol tea polysaccharide composition of efficacy enhancing and toxicity reducing antihepatocarcinoma effect |
CN106376670A (en) * | 2016-08-30 | 2017-02-08 | 广西克鲁尼茶叶生物科技有限公司 | Solid tea beverage prepared from tea polyphenol byproducts and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
夏涛等: "《茶叶深加工技术》", 28 February 2011, 中国轻工业出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111793660A (en) * | 2020-09-02 | 2020-10-20 | 安徽大学 | A radix et rhizoma Rhei tea polysaccharide with blood sugar lowering effect |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bashary et al. | An insight of alpha-amylase inhibitors as a valuable tool in the management of type 2 diabetes mellitus | |
Clouatre et al. | Bitter melon extracts in diabetic and normal rats favorably influence blood glucose and blood pressure regulation | |
CN103445117B (en) | Healthcare radix puerariae nutrition powder capable of preventing alcoholic liver injury | |
Yeh et al. | Effects of yam peel extract against carbon tetrachloride-induced hepatotoxicity in rats | |
JP2006045212A (en) | Oral composition containing specific quinic acid derivative | |
Kimani et al. | Antihyperglycemic activity of Zanthoxylum chalybeum stem bark extracts in diabetic rats | |
EP2540316A1 (en) | Composition for controlling weight gain and food product containing the same | |
Shah et al. | Industrial applications of taro (Colocasia esculenta) as a novel food ingredient: A review | |
JP3302346B2 (en) | Food composition | |
CN107279369A (en) | A kind of preparation method of hypoglycemic yellow tea | |
CN107375430B (en) | Curcumin composition for preventing and treating diabetes and complications | |
JP2010202580A (en) | alpha-GLUCOSIDASE INHIBITOR DERIVED FROM NATURAL MATERIAL | |
KR20160006812A (en) | Compositions for preventing and curing diabetes comprising extract of Paeonia lactiflora | |
CN104306413A (en) | Application of myrica rubra pulp extract | |
CN106389483A (en) | Medical fungi formula for preventing and treating diabetes and preparation method of medical fungi formula | |
JP2002205949A (en) | Method for ameliorating dysbolism and composition therefor | |
Yeap et al. | In vivo antidiabetic and acute toxicity of spray-dried Vernonia amygdalina water extract | |
JP2002053484A (en) | Lipase inhibitor, and food and drink containing the same | |
KR20180132571A (en) | A composition comprising extract of ligularia fischeri and momordica charantia for preventing and treating and manufacturing method thereof | |
Ravi et al. | Hypoglycemic effect of Eugenia jambolana seed kernels on streptozotocin-induced diabetes in rats | |
KR20130041494A (en) | The composition for treating diabetes | |
CN103265493A (en) | Desmodium sequax extractive, as well as extraction method and new application thereof | |
Navitha et al. | Hypoglycemic and anti-diabetic activity of ethanolic extract of Catharanthus pusillus (Murray) G. Don | |
Hamza et al. | Health benefits of Moringa oleifera: Used as an anti-diabetic agent | |
CN102058731B (en) | Preparation of chaste tree twig leaf and fruit extract and anti-inflammatory medical application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171024 |